personalized neoantigen/cancer testis antigen nanovaccine (Nanjing University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepersonalized neoantigen/cancer testis antigen nanovaccine (Nanjing University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStomach NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A